VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models

Title
VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models
Authors
Keywords
p38 pathway, SMN, SMA, VPAC2 receptor agonist, Therapeutics
Journal
Orphanet Journal of Rare Diseases
Volume 9, Issue 1, Pages 4
Publisher
Springer Nature
Online
2014-01-09
DOI
10.1186/1750-1172-9-4

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now